Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Good medication adherence improves quality of life in subclinical thyroid disorder patients.

New drugs are improving treatment for hormone-related diseases in small pets.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Endocrine diseases in dogs often cause skin problems, with hypothyroidism and hyperadrenocorticism being common and leading to hair loss and infections.

Systemic diseases can cause hair loss, which is often reversible with treatment.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Many children with alopecia areata also have other autoimmune diseases.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Managing multiple autoimmune diseases in one patient is very challenging.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

The document suggests managing female pattern hair loss by checking and correcting B12, folate, and thyroid levels, and considering an androgen profile if there are signs of excess androgen.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Eyelash loss can be a sign of thyroid problems.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.